Management Agreements
Health Care Equipment & Supplies
Health Care Equipment & Supplies (44) | Management Agreements (6,701)
- ANTARES PHARMA, INC. (2 contracts)
- APPYEA, INC (1)
- BIOCANCELL THERAPEUTICS INC. (2)
- Bionik Laboratories Corp. (1)
- CESCA THERAPEUTICS INC. (1)
- CryoLife, Inc. (1)
- Danaher Corp. (3)
- Hologic (1)
- Innovative Eyewear Inc (1)
- Invacare Corporation (1)
- INVO Bioscience, Inc. (1)
- Lantheus Holdings, Inc. (1)
- Longview Acquisition Corp. (2)
- Lucid Diagnostics Inc. (9)
- Medifirst Solutions, Inc. (1)
- Outset Medical, Inc. (1)
- PAVmed Inc. (1)
- PERNIX THERAPEUTICS HOLDINGS, INC. (3)
- Presbia PLC (1)
- Quotient Ltd (1)
- REPROS THERAPEUTICS INC. (1)
- SANUWAVE Health, Inc. (3)
- SOLEI SYSTEMS, INC. (1)
- THC Therapeutics, Inc. (1)
- ViewRay, Inc. (1)
- VIVOS INC (1)
- WOUND MANAGEMENT TECHNOLOGIES, INC. (1)
- Seventh Amendment to Management Services Agreement, dated as of May 9, 2023, by and between PAVmed Inc. and Lucid Diagnostics Inc (Lucid Diagnostics Inc., Filed With SEC on May 15, 2023)
- Fifth Amendment to Management Services Agreement, dated as of November 10, 2021, by and between PAVmed Inc. and Lucid Diagnostics Inc (Lucid Diagnostics Inc., Filed With SEC on March 14, 2023)
- Sixth Amendment to Management Services Agreement, dated as of July 1, 2022, by and between PAVmed Inc. and Lucid Diagnostics Inc (Lucid Diagnostics Inc., Filed With SEC on December 2, 2022)
- Cooperation Agreement, dated as of August 22, 2022, by and among Invacare Corporation, Azurite Management LLC and the other parties named therein (Invacare Corporation, Filed With SEC on August 22, 2022)
- Management Services Agreement, dated as of February 25, 2022, by and among LucidDx Labs Inc. and ResearchDx, Inc (Lucid Diagnostics Inc., Filed With SEC on March 3, 2022)
- Management Agreement between Innovative Eyewear, Inc. and Tekcapital Europe Ltd (Innovative Eyewear Inc, Filed With SEC on January 10, 2022)
- MANAGEMENTOPERATING AGREEMENT (SOLEI SYSTEMS, INC., Filed With SEC on January 6, 2022)
- Management Services Agreement, dated as of May 12, 2018, by and between PAVmed Inc. and Lucid Diagnostics Inc (Lucid Diagnostics Inc., Filed With SEC on October 7, 2021)
- Amendment to Management Services Agreement, dated as of March 1, 2019, by and between PAVmed Inc. and Lucid Diagnostics Inc (Lucid Diagnostics Inc., Filed With SEC on October 7, 2021)
- Second Amendment to Management Services Agreement, dated as of June 5, 2019, by and between PAVmed Inc. and Lucid Diagnostics Inc (Lucid Diagnostics Inc., Filed With SEC on October 7, 2021)
- Third Amendment to Management Services Agreement, dated as of July 20, 2020, by and between PAVmed Inc. and Lucid Diagnostics Inc (Lucid Diagnostics Inc., Filed With SEC on October 7, 2021)
- Fourth Amendment to Management Services Agreement, dated as of February 1, 2021, by and between PAVmed Inc. and Lucid Diagnostics Inc (Lucid Diagnostics Inc., Filed With SEC on October 7, 2021)
- Engagement Agreement dated August 24, 2021, between THC Therapeutics, Inc. and Shefford Capital Management, LLC (THC Therapeutics, Inc., Filed With SEC on August 30, 2021)
- Engagement Agreement dated July 7, 2021 between Medifirst Solutions, Inc. and Shefford Capital Management, LLC (Medifirst Solutions, Inc., Filed With SEC on July 7, 2021)
- Management Services Agreement (INVO Bioscience, Inc., Filed With SEC on June 30, 2021)
- Purchasing Agreement by and between HCA Management Services, L.P. and Outset Medical, Inc. dated as of May 1, 2020 (Outset Medical, Inc., Filed With SEC on August 21, 2020)
- Administrative Services Agreement between the Company and Glenview Capital Management, LLC (Longview Acquisition Corp., Filed With SEC on May 27, 2020)
- Form of Administrative Services Agreement by and between the Registrant and Glenview Capital Management, LLC (Longview Acquisition Corp., Filed With SEC on May 1, 2020)
- Support Agreement, dated as of April 14, 2020, among Lantheus Holdings, Inc., Velan Capital, L.P., Altiva Management Inc., Velan Capital Partners LP, Velan Capital Holdings LLC,... (Lantheus Holdings, Inc., Filed With SEC on April 14, 2020)
- Lease extension agreement dated October 2, 2019 among Quotient Limited, FidFund Management SA and Quotient Suisse SA, amending the lease agreement dated March 10, 2010 to extend... (Quotient Ltd, Filed With SEC on February 4, 2020)
- Voting Agreement between CARTXpress Bio, Inc. and Bay City Capital Fund V, L.P. and Bay City Capital Management V LLC (CESCA THERAPEUTICS INC., Filed With SEC on March 26, 2019)
- Sale of Goods Agreement, dated as of December 13, 2018, by and between Bionik Inc. and CHC Management Services, LLC (Bionik Laboratories Corp., Filed With SEC on December 17, 2018)
- Professional Services Agreement dated August 27, 2018 between Wound Management Technologies, Inc., CGI Cellerate RX, LLC and Cellerate, LLC (WOUND MANAGEMENT TECHNOLOGIES, INC., Filed With SEC on November 14, 2018)
- Services Agreement dated as of December 14, 2017, by and between the Company and OCV Management, LLC (Presbia PLC, Filed With SEC on December 14, 2017)
- Agreement for Amendment to Series A and Series B Warrants, by and between the Company and KBB Asset Management, dated as of December 11, 2017 (REPROS THERAPEUTICS INC., Filed With SEC on December 12, 2017)
- Management Services Agreement dated June 9, 2017 (APPYEA, INC, Filed With SEC on June 13, 2017)
- Agreement, dated as of January 13, 2017, by and between ViewRay, Inc. and Puissance Capital Management (ViewRay, Inc., Filed With SEC on May 15, 2017)
- MANAGEMENTSERVICES AGREEMENT (PAVmed Inc., Filed With SEC on November 20, 2015)
- AMENDMENT 2012-1 TO SENIOR MANAGEMENT AGREEMENT (ANTARES PHARMA, INC., Filed With SEC on March 13, 2013)
- Memorandum of Agreement for Strategic Relationship dated August 19, 2011 between Advanced Medical Isotope Corporation and Spivak Management Inc (VIVOS INC, Filed With SEC on March 23, 2012)
- MANAGEMENT AGREEMENT (Danaher Corp., Filed With SEC on February 24, 2012)
- MANAGEMENT AGREEMENT (Danaher Corp., Filed With SEC on July 27, 2011)
- - CONVENIENCE TRANSLATION FROM HEBREW - Agreement Singed and entered into in Tel Aviv this __ day of ________, 2010 By and Between BioCancell Therapeutics Inc. (the Company) And... (BIOCANCELL THERAPEUTICS INC., Filed With SEC on November 5, 2010)
- - CONVENIENCE TRANSLATION FROM HEBREW - Agreement Singed and entered into in Tel Aviv this __ day of ________, 2010 By and Between BioCancell Therapeutics Inc. (the Company) And... (BIOCANCELL THERAPEUTICS INC., Filed With SEC on October 29, 2010)
- MANAGEMENT STOCKHOLDERS AGREEMENT (SANUWAVE Health, Inc., Filed With SEC on September 30, 2009)
- Amendment to Management Stockholders Agreement of SANUWAVE, Inc. (SANUWAVE Health, Inc., Filed With SEC on September 30, 2009)
- SECOND AMENDMENT TO THE MANAGEMENT STOCKHOLDERS AGREEMENT (SANUWAVE Health, Inc., Filed With SEC on September 30, 2009)
- CONFIDENTIAL TREATMENT REQUESTED Confidential Portions of This Agreement Which Have Been Redacted Are Marked With Brackets ([***]). The Omitted Material Has Been Filed Separately... (CryoLife, Inc., Filed With SEC on February 22, 2007)
- MANAGEMENT AGREEMENT (Danaher Corp., Filed With SEC on February 20, 2007)
- SENIOR MANAGEMENT AGREEMENT BY AND BETWEEN (ANTARES PHARMA, INC., Filed With SEC on February 14, 2006)